Benzophenone-2 Concentration and Its Effect on Oxidative Stress and Apoptosis Markers in Rat Brain.


Journal

Neurotoxicity research
ISSN: 1476-3524
Titre abrégé: Neurotox Res
Pays: United States
ID NLM: 100929017

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 07 11 2018
accepted: 29 01 2019
revised: 24 01 2019
pubmed: 23 4 2019
medline: 10 1 2020
entrez: 23 4 2019
Statut: ppublish

Résumé

Benzophenones, frequently used as UV chemical filters, are absorbed through the skin and can exert systemic adverse effects. So far, most of the data are related to their action on sex hormone receptors whereas potential neurotoxic effect is expected mainly on the basis of in vitro studies. The aim of the present study was to determine concentrations of BP-2, oxidative stress and apoptosis markers in the rat brain after topical administration of this compound. Male Wistar rats were treated dermally with BP-2 (100 mg/kg, 4 weeks), and next, blood and tissue BP-2 concentrations and oxidative stress and apoptotic markers in the frontal cortex and hippocampus were determined. After dermal BP-2 administration, blood level of this compound was about 300 ng/ml while in the liver and adipose tissue 1354 and 823 ng/g wt tissue, respectively. In the studied brain structures, the levels of the test compound were from 5 to 19 ng/g tissue. In the hippocampus, where BP-2 level was about 3.5-fold lower than in the frontal cortex, no significant changes in either oxidative stress and apoptosis markers were observed. There was also no change in apoptosis markers in the frontal cortex but unexpectedly the oxidative stress markers were reduced. The research showed that BP-2 passes through the blood-brain barrier but its concentration in the brain structures are much lower than in the blood. This compound did not exacerbate oxidative stress and apoptosis markers in the hippocampus and frontal cortex, and even lowered oxidative stress in the frontal cortex.

Identifiants

pubmed: 31006828
doi: 10.1007/s12640-019-0011-y
pii: 10.1007/s12640-019-0011-y
pmc: PMC6570683
doi:

Substances chimiques

Benzophenones 0
2,2',4,4'-tetrahydroxybenzophenone PRR8K3H9VN

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-48

Références

Br J Clin Pharmacol. 1999 Oct;48(4):635-7
pubmed: 10583038
Biomed Chromatogr. 2002 Aug;16(5):319-26
pubmed: 12210505
Clin Exp Dermatol. 2002 Nov;27(8):691-4
pubmed: 12472548
Toxicology. 2004 Dec 1;205(1-2):87-93
pubmed: 15458793
Toxicology. 2004 Dec 1;205(1-2):103-12
pubmed: 15458795
Toxicology. 2005 Sep 15;213(1-2):13-24
pubmed: 15951094
Arch Toxicol. 2006 Oct;80(10):656-61
pubmed: 16586070
Endocrinology. 2007 Jun;148(6):2835-44
pubmed: 17379648
J Urol. 2007 Oct;178(4 Pt 2):1637-42
pubmed: 17707034
Toxicology. 2008 Mar 12;245(1-2):11-7
pubmed: 18242814
Neurobiol Dis. 2008 Sep;31(3):378-85
pubmed: 18585460
Environ Pollut. 2010 May;158(5):1817-24
pubmed: 20004505
Am J Obstet Gynecol. 1990 Dec;163(6 Pt 2):2138-45
pubmed: 2147818
Chemosphere. 2012 May;87(7):796-802
pubmed: 22277880
Talanta. 2013 Nov 15;116:388-95
pubmed: 24148420
Eur J Med Chem. 2014 May 6;78:157-66
pubmed: 24681980
J Alzheimers Dis. 2014;42 Suppl 3:S125-52
pubmed: 25056458
Mol Med Rep. 2015 Feb;11(2):775-82
pubmed: 25371181
Environ Int. 2015 May;78:45-50
pubmed: 25749637
Fertil Steril. 2015 Oct;104(4):989-996
pubmed: 26253817
Pharmacol Rep. 2016 Feb;68(1):162-71
pubmed: 26721368
Prog Neurobiol. 2017 Oct;157:188-211
pubmed: 26891883
Neurotoxicology. 2016 May;54:44-52
pubmed: 26965011
Neurotox Res. 2017 Apr;31(3):421-435
pubmed: 28247204
Int J Mol Sci. 2017 Mar 25;18(4):
pubmed: 28346357
Environ Int. 2018 Jan;110:51-60
pubmed: 29100749
J Steroid Biochem Mol Biol. 2018 Sep;182:106-118
pubmed: 29704544
Toxicol Lett. 2018 Oct 15;296:63-72
pubmed: 30099065
Toxicol Lett. 1994 Aug;73(2):113-22
pubmed: 8048080
Anal Biochem. 1996 Jul 15;239(1):70-6
pubmed: 8660627

Auteurs

Żaneta Broniowska (Ż)

Department of Biochemical Toxicology Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, PL, Poland.

Beata Bystrowska (B)

Department of Toxicology, Chair of Toxicology, Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, PL, Poland.

Beata Starek-Świechowicz (B)

Department of Biochemical Toxicology Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, PL, Poland.

Bartosz Pomierny (B)

Department of Biochemical Toxicology Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, PL, Poland.

Weronika Krzyżanowska (W)

Department of Biochemical Toxicology Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, PL, Poland.

Maria Walczak (M)

Department of Toxicology, Chair of Toxicology, Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, PL, Poland.

Bogusława Budziszewska (B)

Department of Biochemical Toxicology Medical College, Jagiellonian University, Medyczna 9, 30-688, Kraków, PL, Poland. boguslawa.budziszewska@uj.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH